Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teicoplanin vs Vancomycin in Febrile Neutropenia
NCT00454272Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of teicoplanin in febrile neutropenia (FN) (2 arms), sponsored by Sanofi. Primary endpoint: Clinical Response. Started Jan 2005; status: completed.
02
Drugs
teicoplanin
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT00454272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454272.